PRIMARY TREATMENT OF INCOMPLETE KAWASAKI DISEASE WITH INFLIXIMAB AND METHYLPREDNISOLONE IN A PATIENT WITH A CONTRAINDICATION TO INTRAVENOUS IMMUNE GLOBULIN

Abstract

Incomplete Kawasaki disease was diagnosed in a 3-year-old boy. Because intravenous immune globulin infusion was not tolerated, he was treated with infliximab and methylprednisolone. Coronary aneurysms were not visualized on initial or follow-up echocardiograms. To our knowledge, this is the first report to document the use of infliximab and methylprednisolone as first line therapy for Kawasaki disease.